Aptar Pharma’s site expansion in Congers (NY, USA) was inaugurated on 20 March by Stephan Tanda, AptarGroup’s President and CEO, Salim Haffar, President of Aptar Pharma, and Alex Theodorakis, President Aptar Pharma North America.
Several Aptar Pharma customers in North America were invited to attend this inaugural event.
Aptar Pharma’s newly expanded, state-of-the-art manufacturing capabilities will be used to complete premium injectable elastomeric component manufacturing, enabling Aptar Pharma to better serve its North American pharmaceutical customers.
“The new expansion supports growth in three directions,” explained Bas van Buijtenen, President, Injectables Division, Aptar Pharma.
“It adds capacity to our network of global manufacturing sites and will be equipped with the latest technologies to meet growing quality requirements. The proximity to our North American customer base improves our service and responsiveness.”